{
    "eid": "2-s2.0-84988350405",
    "title": "Clinical Recommendations for the Use of Donepezil 23 mg in Moderate-to-Severe Alzheimer's Disease in the Asia-Pacific Region",
    "cover-date": "2016-09-09",
    "subject-areas": [
        {
            "$": "Psychiatry and Mental Health",
            "@code": "2738"
        },
        {
            "$": "Cognitive Neuroscience",
            "@code": "2805"
        }
    ],
    "keywords": [
        "Acetylcholinesterase inhibitors",
        "Aging",
        "Alzheimer's disease",
        "Dementia",
        "Disease progression",
        "Donepezil",
        "Dose-response relationship"
    ],
    "authors": [
        "Marwan Sabbagh"
    ],
    "citedby-count": 10,
    "ref-count": 42,
    "ref-list": [
        "World Alzheimer Report 2015-The Global Impact of Dementia: An Analysis of Prevalence, Incidence, Cost and Trends",
        "Epidemiology of dementia in Asia: Insights on prevalence, trends and novel risk factors",
        "Risk factors of caregiver burden among patients with Alzheimer's disease or related disorders: A cross-sectional study",
        "Dementia in the Asia Pacific Region",
        "Resource utilisation and cost analysis of memantine in patients with moderate to severe Alzheimer's disease",
        "Cost related to dementia in the young and the impact of etiological subtype on cost",
        "The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer\u2019s Disease",
        "Aricept (Donepezil Hydrochloride): Highlights of Prescribing Information.",
        "Exelon (Rivastigmine): Highlights of Prescribing Information.",
        "Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study",
        "Progressive cholinergic decline in Alzheimer's Disease: Consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology",
        "Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzeimer's disease",
        "Brain Acetylcholine and Neuropsychiatric Disease",
        "Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: Results from a 24-week, double-blind, placebo-controlled, randomized trial",
        "Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: A meta-analysis of individual patient data from randomised controlled trials",
        "Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan",
        "Safety and tolerability of donepezil at doses up to 20 mg/day: Results from a pilot study in patients with Alzheimer's disease",
        "Efficacy and safety of donepezil 23 mg versus donepezil 10 mg for moderate-to-severe Alzheimer's disease: A subgroup analysis in patients already taking or not taking concomitant memantine",
        "Safety and tolerability of donepezil 23 mg in moderate to severe alzheimer's disease",
        "Long-term safety and tolerability of donepezil 23mg in patients with moderate to severe Alzheimers disease",
        "The role of ethnicity in variability in response to drugs: Focus on clinical pharmacology studies",
        "Interethnic differences in dementia epidemiology: Global and Asia-Pacific perspectives",
        "Donepezil 23 mg in Asian patients with moderate-to-severe Alzheimer's disease",
        "Alzheimer disease",
        "Long-term progression of Alzheimer's disease in patients under antidementia drugs",
        "Family caregiving in dementia: The asian perspective of a global problem",
        "Why family caregivers choose to institutionalize a loved one with dementia: A singapore perspective",
        "Effects of donepezil 23 mg on Severe Impairment Battery domains in patients with moderate to severe Alzheimer's disease: Evaluating the impact of baseline severity",
        "Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: Analysis of effects of baseline features on treatment response",
        "Severe Impairment Battery Language scale: A language-assessment tool for Alzheimer's disease patients",
        "A longitudinal study of language decline in Alzheimer's disease and frontotemporal dementia",
        "Analyzing the impact of 23 mg/day donepezil on language dysfunction in moderate to severe Alzheimer's disease",
        "Review of Alzheimer's disease scales: Is there a need for a new multi-domain scale for therapy evaluation in medical practice?",
        "Assessment of the Severely Impaired Patient: Description and Validation of a New Neuropsychological Test Battery",
        "Development of a short form of the severe impairment battery",
        "Survival of alzheimer's disease patients in Korea",
        "Ann Psychiatry Ment Health",
        "Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23 Mg (ODESA)",
        "Defining optimal treatment with cholinesterase inhibitors in Alzheimer's disease",
        "Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: Secondary and post-hoc analyses",
        "Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease",
        "Risk factors for nursing home placement in Alzheimer's disease: A longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Siriraj Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Seongnam",
            "affilname": "Seoul National University Bundang Hospital",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Singapore City",
            "affilname": "Duke-NUS Medical School",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Ahmedabad",
            "affilname": "SAL Hospital and Medical Institute",
            "affiliation-country": "India"
        },
        {
            "affiliation-city": "Manila",
            "affilname": "University of Santo Tomas Hospital",
            "affiliation-country": "Philippines"
        },
        {
            "affiliation-city": "Central Jakarta",
            "affilname": "Universitas Indonesia, RSUPN Dr. Cipto Mangunkusumo",
            "affiliation-country": "Indonesia"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Seoul",
            "affilname": "Konkuk University Graduate School of Medicine",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "affilname": "Mahidol University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Seoul",
            "affilname": "University of Ulsan College of Medicine",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Tainan",
            "affilname": "National Cheng Kung University College of Medicine",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Phoenix",
            "affilname": "Barrow Neurological Institute",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Seoul",
            "affilname": "Seoul National University College of Medicine",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Mumbai",
            "affilname": "Eisai Pharmaceuticals India Pvt. Ltd.",
            "affiliation-country": "India"
        },
        {
            "affiliation-city": "Seongnam",
            "affilname": "Bobath Memorial Hospital",
            "affiliation-country": "South Korea"
        }
    ],
    "funding": []
}